Don’t miss the latest developments in business and finance.

Home / India News / Alembic Pharmaceuticals receives approval for Darifenacin ER Tablets

Alembic Pharmaceuticals receives approval for Darifenacin ER Tablets

Image
Capital Market
Last Updated : Dec 12 2017 | 11:31 AM IST
Connect with us
Facebook IconLinkedIN Icon

From USFDA

Alembic Pharmaceuticals has received USFDA approval for Darifenacin Extended-Release Tablets, 7.5 mg and 15 mg. Darifenacin Extended-Release Tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.

Powered by Capital Market - Live News

Connect with us on WhatsApp

Also Read

Alembic Pharmaceuticals gets ANDA approval for Candesartan Cilexetil Tablets

Alembic Pharmaceuticals gets tentative approval for Vardenafil Hydrochloride Orally Disintegrating Tablets

Alembic Pharmaceuticals gets ANDA approval for Olmesartan Medoxomil and Amlodipine Tablets

Alembic Pharmaceuticals receives ANDA approval for Amantadine Hydrochloride Capsules

Glenmark Pharmaceuticals receives final approval for Nitroglycerin Sublingual Tablets

First Published: Dec 12 2017 | 11:07 AM IST

Explore News

Next Story